Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-12T02:08:51.328Z Has data issue: false hasContentIssue false

Navigating the Regulatory Framework for HIV Prevention Research in Adolescents

Published online by Cambridge University Press:  01 January 2021

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Independent Articles: Commentary
Copyright
Copyright © American Society of Law, Medicine and Ethics 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Centers for Disease Control and Prevention, HIV and Youth, available at <https://www.cdc.gov/hiv/group/age/youth/index.html> (last visited February 24, 2020).+(last+visited+February+24,+2020).>Google Scholar
See Centers for Disease Control and Prevention, supra note 1.Google Scholar
45 CFR § 46 (2018).Google Scholar
45 CFR § 46 (2018).Google Scholar
21 U.S.C. § 301–399h (2019).Google Scholar
21 CFR § 50.55 (2019).Google Scholar
21 CFR § 50.3 (o) (2019).Google Scholar
Bauman, L.J., Mellins, C.A., and Klitzman, R., “Whether to Waive Parental Permission in HIV Prevention Research Among Adolescents: Ethical and Legal Considerations,” Journal of Law, Medicine & Ethics 48, no. 1 (2020): 188201.CrossRefGoogle Scholar
Moore, Q.L., Paul, M.E., Mcguire, A.L., and Majumder, M.A., “Legal Barriers to Adolescent Participation in Research About HIV and Other Sexually Transmitted Infections,” American Journal of Public Health 106, no. 1 (2016): 4044.CrossRefGoogle Scholar
Food and Drug Administration, HIV-1 PrEP drug can be part of a strategy to prevent infection in at-risk adolescents, available at <https://www.fda.gov/files/science%20&%20research/published/HIV-PrEP-drug-can-be-part-of-strategy-to-prevent-infection-in-at-risk-adolescents.pdf> (last visited February 24, 2020)+(last+visited+February+24,+2020)>Google Scholar
Centers for Disease Control and Prevention, Minors’ Consent Laws for HIV and STD Services, available at <https://www.cdc.gov/hiv/policies/law/states/minors.html> (last visited February 24, 2020).+(last+visited+February+24,+2020).>Google Scholar
Guttmacher Institute, Minors’ Access to STI Services, available at <https://www.guttmacher.org/state-policy/explore/minors-access-sti-services> (last visited February 24, 2020).+(last+visited+February+24,+2020).>Google Scholar
See Centers for Disease Control and Prevention, supra note 11.Google Scholar
See Moore, supra note 9.Google Scholar
Gilbert, A.L., Knopf, A.S., Fortenberry, J. D., Hosek, S.G., Kapogiannis, B.G., and Zimet, G. D., “Adolescent Self-Consent for Biomedical Human Immunodeficiency Virus Prevention Research,” Journal of Adolescent Health 57, no. 1 (2015): 113119.CrossRefGoogle Scholar
Food and Drug Administration, supra note 10.Google Scholar
Food and Drug Administration, supra note 10.Google Scholar
Centers for Disease Control and Prevention, HIV in the Southern United States, available at <https://www.cdc.gov/hiv/pdf/policies/cdc-hiv-in-the-south-issue-brief.pdf> (last visited February 24, 2020).+(last+visited+February+24,+2020).>Google Scholar